Search
for
Sort by
Research 451–480 of 1000+
- Hormone replacement therapy and COVID-19 outcomes in solid organ transplant recipients compared with the general population
- COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection?
- Telogen Effluvium and COVID-19: a case and a brief review of literature
- COVID-19 Can Exacerbate Pattern Hair Loss and Trigger Telogen Effluvium - The Role of Proteoglycan Replacement Therapy with Nourkrin® in Clinical Treatment of COVID-19 Associated Hair Loss
- The COVID-19 Sequelae: A Cross-Sectional Evaluation of Post-recovery Symptoms and the Need for Rehabilitation of COVID-19 Survivors
- COVID ‐19 induced telogen effluvium
- Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors
- Preliminary Investigation on Micro-Needling with Low-Level LED Therapy and Growth Factors in Hair Loss Related to COVID-19
- The role of autologous micrografts injection from the scalp tissue in the treatment of COVID‐19 associated telogen effluvium: Clinical and trichoscopic evaluation
- COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy
- SARS-CoV-2 Infection and COVID-19 Vaccination Associated with Post-Acute Alopecia: Prevalence, Clinical Patterns, and Determinants Among Saudi Adults
- Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data
- Alopecia in patients with COVID-19: A systematic review and meta-analysis
- Skin manifestations associated with COVID-19
- Associations between clinical data, vaccination status, antibody responses, and post-COVID-19 symptoms in Thais infected with SARS-CoV-2 Delta and Omicron variants: a 1-year follow-up study
- Cutaneous Manifestations of COVID-19: A Brief Review of a Possible Diagnostic Tool
- CAPILLARY DISEASES IN PATIENTS WHO HAD COVID-19
- Therapeutics for COVID-19 and post COVID-19 complications: An update
- Post-COVID-19 Syndrome Mechanisms, Prevention and Management
- Post-acute COVID-19 symptom risk in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis
- Post-COVID-19 syndrome among hospitalized COVID-19 patients: a cohort study assessing patients 6 and 12 months after hospital discharge
- Complications Post-COVID-19 and Risk Factors among Patients after Six Months of a SARS-CoV-2 Infection: A Population-Based Prospective Cohort Study
- Antiandrogens as Therapies for COVID-19: A Systematic Review
- Role of ACE2 polymorphism in COVID-19: impact of age
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Estimating long COVID-19 prevalence across definitions and forms of sample selection
- [Review of the post-COVID-19 syndrome associated to acute telogen effluvium].
- Post-Acute COVID-19 Sequelae – ‘COVID Long Hauler’
- Sex steroid hormones are associated with mortality in COVID-19 patients
- Post-COVID-19 Sydrome and Decrease in Health-Related Quality of Life in Kidney Transplant Recipients after SARS-COV-2 Infection—A Cohort Longitudinal Study from the North of Poland